Full Professor(heuristic)

Colorectal Cancer Treatments and Studies · Oncology

h-index66
i10-index174
Publications483
Citations16,153

Grants

10 total · 0 active

NIH #5UH3CA207101-05

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$150K
Period
2018-09-21 → 2025-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-05

Core 1: Biospecimen and Pathology Core

Amount
$274K
Period
2019-08-20 → 2025-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH3CA207101-04

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$341K
Period
2018-09-21 → 2024-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

10 total · 0 active

NIH #5UH3CA207101-05

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$150K
Period
2018-09-21 → 2025-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-05

Core 1: Biospecimen and Pathology Core

Amount
$274K
Period
2019-08-20 → 2025-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH3CA207101-04

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$341K
Period
2018-09-21 → 2024-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #4UH3CA207101-03

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$297K
Period
2018-09-21 → 2024-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-04

Core 1: Biospecimen and Pathology Core

Amount
$277K
Period
2019-08-20 → 2024-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-03

Core 1: Biospecimen and Pathology Core

Amount
$248K
Period
2019-08-20 → 2024-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5P50CA221707-02

Core 1: Biospecimen and Pathology Core

Amount
$281K
Period
2019-08-20 → 2024-05-31
PIs
1
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #5UH2CA207101-02

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$164K
Period
2018-09-21 → 2020-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1UH2CA207101-01A1

Colorectal Cancer Molecular Subtype Assay Development and Validation

Amount
$214K
Period
2018-09-21 → 2020-08-31
PIs
4
Est. capacity / PI
~0 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

NIH #1P50CA221707-01A1

Core 1: Biospecimen and Pathology Core

Amount
$275K
Period
— → —
PIs
1
Est. capacity / PI
~4 students

Awarded at UNIVERSITY OF TX MD ANDERSON CAN CTR

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 10 of 10
Open author page on OpenAlex →